Cyprotex is the largest specialty in vitro ADMET company and is the only company in the world offering in silico PBPK modeling along side with a comprehensive suite of standard industry and proprietary ADME and toxicology assays. The company is build on advanced automation platform allowing high-throughput screening of drug candidates and on cutting edge science for proprietary ADME and toxicology assays. These capabilities allow customers to rapidly screen out the compounds most likely to fail in the clinic and focus resources on candidates most likely to succeed. The company has high Ph.D. ratio and large number oaf study managers with 10+ years experience in drug discovery.